JC, C., X, J., Q, L., N, G., K, M., HA, B., . . . E, I. (2019). Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate. The Journal of allergy and clinical immunology, 144(2), 416. https://doi.org/10.1016/j.jaci.2019.01.049
Chicago Style (17th ed.) CitationJC, Cardet, et al. "Loss of Bronchoprotection with ICS Plus LABA Treatment, β-receptor Dynamics, and the Effect of Alendronate." The Journal of Allergy and Clinical Immunology 144, no. 2 (2019): 416. https://doi.org/10.1016/j.jaci.2019.01.049.
MLA (9th ed.) CitationJC, Cardet, et al. "Loss of Bronchoprotection with ICS Plus LABA Treatment, β-receptor Dynamics, and the Effect of Alendronate." The Journal of Allergy and Clinical Immunology, vol. 144, no. 2, 2019, p. 416, https://doi.org/10.1016/j.jaci.2019.01.049.